RNS Number:6481O
LiDCO Group Plc
14 August 2003






                   LIDCO GROUP PLC ("LIDCO" OR THE "COMPANY")


Registration of LiDCO's PulseCO System in Japan


Following the conclusion of clinical trials and the subsequent regulatory
submission, LiDCO, the AIM traded hemodynamic monitoring company, have been
informed by their Japanese distributor, Nipro Corporation ("Nipro" Reuters code
8086.T) of the successful registration of the PulseCO Monitor in Japan. Nipro
have purchased a substantial number of PulseCO Monitors and LiDCO expects launch
of the PulseCO System in Japan in Q4 of 2003.


Dr Terry O'Brien, LiDCO's Chief Executive, stated: 'We are delighted to report
the registration of the PulseCO System in Japan. The Japanese market is the
second biggest market in the world for hemodynamic monitoring. We are looking
forward to working with our partners at Nipro to establish the PulseCO Monitor
as the technology of choice for continuous hemodynamic monitoring.'


LiDCO announces that the date of the publication of the Company's interim
results for the half year ending 30th June 2003 will be the 23 September 2003.



Enquiries:
LiDCO Group Plc                                                  020-7749 1500
Terry O'Brien (CEO) terry@lidco.com
-------------------------------------
Richard Mills (FD) Richard@lidco.com
--------------------------------------

Bankside Consultants Limited
Charles Ponsonby (PR) charles.ponsonby@bankside.com              020-7444 4166
-----------------------------------------------------
Chris Munden (IR) chris.munden@bankside.com                      020-7444 4150
---------------------------------------------







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCGGGMRVFLGFZM